SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,294.96 -19.63
( -0.03%)

Global Indices

Nasdaq

51,699.28 -99.76
(-0.19%)

Dow Jones

7,668.45 9.69
(0.13%)

Hang Seng

65,040.24 903.99
(1.41%)

Nikkei 225

10,654.81 -161.33
(-1.49%)

Forex

USD-INR

95.87 0.21
(0.22%)

EUR-INR

110.00 -0.22
(-0.20%)

GBP-INR

128.18 -0.44
(-0.35%)

JPY-INR

0.61 0.00
(-0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

18.6032787

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

46.03

88.45

EPS(TTM)

Face Value()

Div & Yield %

1.26

Back

supra pacific financial services ltd

Salem Erode Investments reports standalone net loss of Rs 1.31 crore in the June 2026 quarter

Aug 14,2026

Net Loss of Salem Erode Investments reported to Rs 1.31 crore in the quarter ended June 2026 as against net loss of Rs 0.99 crore during the previous quarter ended June 2025. Sales declined 18.35% to Rs 0.89 crore in the quarter ended June 2026 as against Rs 1.09 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	0.89	1.09	-18
OPM %	-65.17	-23.85	-
PBDT	-1.00	-0.68	-47
PBT	-1.26	-0.99	-27
NP	-1.31	-0.99	-32

74,294.96 -19.63 ( -0.03%)

51,699.28 -99.76 (-0.19%)

7,668.45 9.69 (0.13%)

65,040.24 903.99 (1.41%)

10,654.81 -161.33 (-1.49%)

95.87 0.21 (0.22%)

110.00 -0.22 (-0.20%)

128.18 -0.44 (-0.35%)

0.61 0.00 (-0.09%)